Investment Portfolio Analysis
Find education and training classes and material for both professional and individual investors.
Why Porfolio Doctor should be your go-to analytical tool for smart investment ?
PortfolioDoctor.ai is a web-based platform catering to individuals who would like to have some control over their portfolios. By providing easy to use and easy to understand analytical tools to management risk and construct optimal portfolios, our platform aims at democratizing “equity analysis” and leveling the play field for ordinary people with limited knowledge about the capital market. More sophisticated investors can also benefit from the datadriven insights based upon traditional analysis and machine learning algorithms. Any user of this platform can be empowered to be an insightful equity analyst commensurable to those at the research desk in big Wall Street firms. Specifically, you will be able to perform following critical functions using the system:
Stock (and ETF) mining and discovery
Valuation analysis: Price target and suggested entry point (with high confidence): 12-month price target
e price target is estimated by considering three factors: outlook of earning power, stock rating wall street analysts, market sentiment based upon social media (guru discussion in news & individual trader chat). Macro and Policy trends are also considered. The weights on each factor are determined by both learning algorithms and traditional statistical analysis.
Benchmarking with sector peers and competitors
capital market, the fair value of an asset is always relative. No true value can be revealed without comparison study of other assets with similar attributes. Our platform makes such comparison easier and intuitive.
Risk assessment:
• Market risk (Price movement pattern and trading risk, volatility and Maximum Drawdown, etc)
• Credit risk (i.e. the company’s financial healthiness)
• Liquidity Risk (How active the stock/ETF is traded)
• Financial Statement fraud risk (The probability of manipulation of the financial disclosure by the company is estimated.)